MedPath

Evaluation of Dexmedetomidine effect on mentally-disabled adults, candidate for dental treatment under general aneasthesia

Phase 2
Recruiting
Conditions
mental disability.
Unspecified intellectual disabilities
Registration Number
IRCT20190626044013N2
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

mentally disabled
without systemic diseases or physical disabilities
need dental treatment under general aneasthesia

Exclusion Criteria

unwilling to participate in the study
using tranquillizers, anticonvulsive, antidepressants, antipsychotic drugs
allergic to soy or eggs
hepatic diseases
Morbidly obese (BMI=40)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Agitation in recovery. Timepoint: once. Method of measurement: Richmond Scale.
Secondary Outcome Measures
NameTimeMethod
Heart rate. Timepoint: Once every 15 minutes during anesthesia. Method of measurement: pulsometer.;Anesthesia time. Timepoint: Once during anesthesia. Method of measurement: clock.;Analgesia need in recovery. Timepoint: Once during the patient's recovery. Method of measurement: recording.;Recovery time. Timepoint: Once during the patient's recovery. Method of measurement: clock.;Systolic blood pressure. Timepoint: Once every 15 minutes during anesthesia. Method of measurement: pressure cuff.
© Copyright 2025. All Rights Reserved by MedPath